SCA
CRL icon

Stonebridge Capital Advisors’s Charles River Laboratories CRL Stock Holding History

Stonebridge Capital Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3
Closed -$588 – 350
2023
Q3 		$588 Sell
3
-23
-88% -$4.72K ﹤0.01% 877
2023
Q2 		$5.47K Buy
26
+23
+767% +$4.58K ﹤0.01% 708
2023
Q1 		$605 Hold
3
– – ﹤0.01% 887
2022
Q4 		$654 Sell
3
-31
-91% -$6.77K ﹤0.01% 889
2022
Q3 		$7K Buy
34
+9
+36% +$1.94K ﹤0.01% 631
2022
Q2 		$5K Hold
25
– – ﹤0.01% 700
2022
Q1 		$7K Hold
25
– – ﹤0.01% 718
2021
Q4 		$9K Hold
25
– – ﹤0.01% 651
2021
Q3 		$10K Buy
+25
New +$10.4K ﹤0.01% 619

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return